Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000102909-26-000162·Keros Therapeutics, Inc.
Schedule 13G ownership disclosure
Keros Therapeutics Inc
Common Stock · CUSIP: 492327101
Event date: 2025-12-31
- Filing-level shares
- 1,525,355
- Percent of class
- 5%
- The Vanguard Group
Shares: 1,525,355 · Class: 5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000102909-26-000162
- Form type
- SCHEDULE 13G/A
- Filer
- Keros Therapeutics, Inc.
- CIK
- CIK 1664710
- Filed
- Jan 30, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership